-transparent.png){kind=logo}
Animal studies were done using an in vivo dog model to examine the possible mechanism for the esophageal adverse events reported with alendronate sodium tablets. These studies showed that under low pH conditions alendronate sodium can cause esophageal irritation. No esophageal irritation occurred at pH 3.5 or higher where the drug exists primarily as the sodium salt. The animal studies also showed that alendronate sodium can exacerbate preexisting esophageal damage. Exposure of the esophageal mucosa for a prolonged period to alendronate sodium tablet can also cause mild esophageal irritation. These findings suggest that the esophageal irritation in patients taking Fosamax can be from prolonged contact with the tablet, reflux of acidic gastric contents with alendronate sodium, and exacerbation of preexisting esophageal damage. The findings also suggest that other bisphosphonates can cause esophageal injury under similar conditions.
C P Peter, and
L K Handt, and
S M Smith
July 1997,
The American journal of nursing,
C P Peter, and
L K Handt, and
S M Smith
May 2011,
Gastrointestinal endoscopy,
C P Peter, and
L K Handt, and
S M Smith
August 1996,
Endoscopy,
C P Peter, and
L K Handt, and
S M Smith
February 2003,
Contact dermatitis,
C P Peter, and
L K Handt, and
S M Smith
May 2013,
Journal of pharmaceutical sciences,
C P Peter, and
L K Handt, and
S M Smith
April 2006,
Archives of pharmacal research,
C P Peter, and
L K Handt, and
S M Smith
July 1995,
Journal of pharmaceutical and biomedical analysis,
C P Peter, and
L K Handt, and
S M Smith
June 2012,
Anales de pediatria (Barcelona, Spain : 2003),
C P Peter, and
L K Handt, and
S M Smith
January 2013,
Profiles of drug substances, excipients, and related methodology,
C P Peter, and
L K Handt, and
S M Smith
August 2008,
Allergy,
